Finding the best ways to help people quit smoking using medications and virtual support.
Comparative Effectiveness of Sequential Pharmacotherapeutic Strategies and Virtually Delivered Treatment to Optimize Smoking Cessation
This study is looking for ways to help adults quit smoking by testing different medications and virtual counseling options, so if you're trying to quit, you might get personalized support to find what works best for you!
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11002710 on NIH RePORTER |
What this research studies
This research aims to improve smoking cessation methods by comparing different medication strategies and virtual counseling for smokers. It will involve a large group of adult participants who are trying to quit smoking, using a Sequential Multiple Assignment Randomized Trial (SMART) design to tailor treatments based on individual responses. Participants will receive either varenicline or nicotine replacement therapy, and those who do not succeed will have options to continue, switch, or enhance their treatment. The goal is to provide effective, accessible support for smokers through virtual delivery, making it easier for them to quit.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are motivated to quit smoking.
Not a fit: Patients who are not seeking to quit smoking or are under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized smoking cessation treatments that are easily accessible to patients.
How similar studies have performed: Previous research has shown promising results with similar pharmacotherapy and counseling approaches for smoking cessation, indicating potential for success in this study.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Cinciripini, Paul Michael — University of Tx Md Anderson Can Ctr
- Study coordinator: Cinciripini, Paul Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.